Results 151 to 160 of about 72,444 (262)

Metabolic Dysfunction‐Associated Fatty Liver Disease: From Pathogenesis to Treatment

MedComm, Volume 7, Issue 7, July 2026.
Extracellular vesicles play a crucial role in interorgan crosstalk of adipose–liver and gut–liver axes and hold potential as therapeutic targets and drug delivery systems for metabolic dysfunction‐associated fatty liver disease (MAFLD). Abbreviations: AT: adipose tissue; EVs: extracellular vesicles; HL: healthy liver; NAFL: nonalcoholic fatty liver ...
Zhifu Cui, Xiaxia Du, Felix Kwame Amevor, Yaoyao Xia, You Yang, Lingbin Liu   +5 more
wiley   +1 more source

Why does hepatitis B remain underprioritized? A view through lived experience. [PDF]

World J Methodol
Ibrahim Y, Qureshi A, Jackson M, Zovich B, Freeland C, Flomo M, Alik K, Yakubov R, Chen LH, Yeboah PK, Cohen C.   +10 more
europepmc   +1 more source

CD8+ Tissue‐Resident Memory T Cells in Health and Disease

MedComm, Volume 7, Issue 7, July 2026.
CD8+ TRM cells are at the center of immunity, mediating potent local innate and adaptive immune responses. While TRM cells mediate protective immunity against infections and tumors, they also contribute to pathological inflammation in autoimmune conditions.
Yu‐Han Ai, Ting‐Ting Xu, Sen Lin, Meng‐Yu Xiao, Yun‐Xia Lin, Hao‐Wen Ma, Yue‐Yang Liu, Yao‐Jie Wang, Lu‐Ning Yin, Mei Huang, Yong‐Da Liu, Chao Zhu, Xiao‐Ting Zhu, Ji‐Hang Yuan   +13 more
wiley   +1 more source

Temporal trends of vaccination coverage in children under five in Brazil, 1998-2024. [PDF]

BMC Public Health
Rago CAP, de Novais MAP, Zucchi P.
europepmc   +1 more source

De Novo Synthesis in Cancer Immunotherapy: Applications and Prospects

MedComm, Volume 7, Issue 7, July 2026.
De novo protein design creates novel structures for cancer immunotherapy, integrating rational design principles like modularity and specificity. Leveraging computational tools, it optimizes cytokine engineering, adoptive cellular therapy, and checkpoint regulation to enhance antitumor immunity.
Yang Jin, Yanfeng Wu, Jianhua Luo
wiley   +1 more source

Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination. [PDF]

Hum Vaccin Immunother
Yuan J, Ding Y, Wang Z, Su L, Li K.
europepmc   +1 more source

A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction. [PDF]

Front Immunol
Jin X, Tang Y, Ma Y, Li M, Gao Y.
europepmc   +1 more source

Dysregulated Metabolism in People Living With HIV in the Modern ART‐Era: A Systematic Review of Targeted Metabolomics Studies

Reviews in Medical Virology, Volume 36, Issue 4, July 2026.
ABSTRACT HIV remains a significant public health issue, with 1.3 million new infections and 630,000 deaths annually, and 40.8 million people living with HIV (PLHIV) globally in 2024. Although antiretroviral therapy (ART) suppresses viral replication, it does not eradicate the virus, and metabolic dysregulation persists despite treatment.
Levanco K. Asia, Du Toit Loots, Shayne Mason, Esme Jansen Van Vuren, Monray E. Williams   +4 more
wiley   +1 more source

Immunogenicity and safety of co-administered <i>Escherichia coli</i>-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine. [PDF]

Front Immunol
Yan R, Cen M, Zhou Y, Ma L, Zhou X, He H, Qi X, Tang X, Liang H, Chen Y, Qi J, Yang S.   +11 more
europepmc   +1 more source

Semiparametric Panel Count Model, With Applications to Signal Detection in Post‐Market Drug Surveillance Systems

Statistics in Medicine, Volume 45, Issue 15-17, July 2026.
ABSTRACT Panel count data occurs in a wide variety of applications, ranging from biomedical research to business, such as the number of accidents, product defects, and insurance claims. For such data under the FDA investigation, millions of reported adverse events (AEs) associated with thousands of drugs are monitored in the post‐market drug safety ...
Yizhao Zhou, Ao Yuan, Ming Tan
wiley   +1 more source